基本资料
投资组合
财务数据
基金公告
港股通创新药ETF万家(520700) |
净值:
1.6539
|
日增长率:
-0.37%
|
累计净值:1.6539 | 2026-09-28 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| 02269 | 药明生物 | 2,463,500.00 | 74,032,683.21 | 10.58 |
| 01801 | 信达生物 | 1,021,000.00 | 70,588,448.18 | 10.09 |
| 06160 | 百济神州 | 458,700.00 | 67,888,022.00 | 9.70 |
| 02359 | 药明康德 | 436,600.00 | 58,284,412.54 | 8.33 |
| 09926 | 康方生物 | 650,000.00 | 49,709,287.88 | 7.10 |
| 01093 | 石药集团 | 7,124,000.00 | 43,127,224.89 | 6.16 |
| 03692 | 翰森制药 | 1,606,000.00 | 41,316,680.31 | 5.90 |
| 01177 | 中国生物制药 | 9,911,000.00 | 37,962,157.81 | 5.42 |
| 01530 | 三生制药 | 1,793,000.00 | 26,302,968.43 | 3.76 |
| 06990 | 科伦博泰生物 | 60,400.00 | 22,883,235.20 | 3.27 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-06-30 | 99.31 | - | 0.50 | 699,816,562.93 |
| 2026-03-31 | 99.57 | - | 0.50 | 841,760,979.11 |
| 2025-12-31 | 99.36 | - | 0.72 | 884,313,571.59 |
| 2025-09-30 | 99.31 | - | 0.72 | 999,325,935.13 |
| 2025-06-30 | 99.35 | - | 6.19 | 485,001,905.71 |